Cervical Cancer Susceptible Population Classification

Recruiting Observational Study
Cervical Cancer Susceptible Population Classification
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Observational
Participants needed
10,000 (estimated)
Sponsor
Anhui Provincial Hospital · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Cervical cancer is the third most common lethal tumor globally, causing around a quarter million deaths annually, despite the availability of HPV vaccines. Recent Genome-wide association studies (GWAS) have identified numerous genetic markers linked to cervical cancer, including rs10175462, rs10007915, rs35721900, and rs61646675, which have been verified as being related to susceptibility to cervi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Subjects aged \>=18 years at time of consent 2. Intended to undergo screening colposcopy 3. Considered by a physician or healthcare provider as being of "average risk" for cervical cancer 4. Willing to consent to blood draw cervical disease treatments 5. Willing to sonsent to…
Contacts

Yingying Wang, Doctor

18652270921

yingyingwang@ustc.edu.cn

CONTACT

Tingting Zhao, Master

17333296213

heyppy@163.com

CONTACT